# Dishman Carbogen Amcis Limited, Ahmedabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/dishman-carbogen-amcis-limited/d3284991-5957-400b-8562-f745b3c4bd73

> Inspection records and compliance data for Dishman Carbogen Amcis Limited in Ahmedabad. 5 FDA inspections on record, last inspected June 12, 2025.

---

## Details

- Name: Dishman Carbogen Amcis Limited
- FEI Number: 1000607691
- Business Operations: API MANUFACTURE
- Address Line 1: 1216/11 - 12 1216/24 25&26 Phase Iv, Gidc Estate
- City: Ahmedabad
- Country Name: India
- Address: 1216/11 - 12 1216/24 25&26 Phase Iv, Gidc Estate, Ahmedabad, India
- Country: India

## Related Documents

- [FDA Inspection 1275944 - Dishman Carbogen Amcis Limited - 2025-06-12](https://www.keypedia.com/records/fda_inspections/dishman-carbogen-amcis-limited/d98971df-23fe-4d7d-8490-8288d4af6346) — source: FDA, date: June 12, 2025
- FDA Inspection 1275944 - Dishman Carbogen Amcis Limited - 2025-06-12 — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2025
- EMA GMP - Dishman Carbogen Amcis Limited - CH20-0177 - 2020-04-20 — source: EMA, date: April 20, 2020
- FDA Inspection 1085004 - Dishman Carbogen Amcis Limited - 2019-02-15 — classification: No Action Indicated (NAI), source: FDA, date: February 15, 2019
- FDA Inspection 945783 - Dishman Carbogen Amcis Limited - 2015-10-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 22, 2015
- FDA Inspection 834065 - Dishman Carbogen Amcis Limited - 2013-05-02 — classification: No Action Indicated (NAI), source: FDA, date: May 2, 2013
- FDA Inspection 651851 - Dishman Carbogen Amcis Limited - 2010-02-04 — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2010

## Related Companies

- [Hubei Haosun Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/hubei-haosun-pharmaceutical-co-ltd/a8ee3f4d-8f6b-432f-8452-d04dc31a1eee)
- [Changzhou Yinsheng Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/changzhou-yinsheng-pharmaceutical-co-ltd/1733699b-c043-4f11-9c7f-f897247a8ea8)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Alchem International Ltd.](https://www.keypedia.com/companies/alchem-international-ltd/e0374c19-b004-479a-b1c1-489fad51c063)
- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Anqiu Lu'an Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/anqiu-luan-pharmaceutical-co-ltd/18b1a266-0f5f-46cc-99de-8ee48dd42b49)